<DOC>
	<DOCNO>NCT02874144</DOCNO>
	<brief_summary>To evaluate efficacy anti-inflammatory agent compare placebo relieve sign symptom disease patient sinusitis .</brief_summary>
	<brief_title>Anti-Inflammatory Agent Sinusitis</brief_title>
	<detailed_description>This Phase 2a , single-center , randomize , placebo-controlled , double-blind study include 12 week treatment experimental drug anti-inflammatory agent placebo TID administer orally . All subject â‰¥18 year , sinusitis persistent symptom despite standard care treatment , fail course steroid past .</detailed_description>
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Nasal Polyps</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>1 . Females must negative urine pregnancy test screen unless document hysterectomy postmenopausal . 1 . Inability unwillingness participant give write informed consent comply study protocol 2 . Use investigational drug within 30 day screen . 3 . Acute infection need antibiotic treatment screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>